Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

NVAX stock continues to languish for want of evidence for a sustainable fundamental improvement. The 2022 revenue guidance issued by the company did stir some optimism, but investors have quickly fallen back to their guarded stance.

The post Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock appeared first on InvestorPlace.

• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”